References
- Cheung VY. Current status of high-intensity focused ultrasound for the management of uterine adenomyosis. Ultrasonography 2017;36(02):95-102
- Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem 2015;27:671-676
- Lee JS, Hong GY, Lee KH, Song JH, Kim TE. Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis. Ultrasound Med Biol 2019;45(12):3214-3221
- Lee JS, Hong GY, Park BJ, Kim TE. Ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroid & adenomyosis: a single center experience from the Republic of Korea. Ultrason Sonochem 2015;27:682-687
- Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH. High-intensity focused ultrasound: current potential and oncologic applications. AJR Am J Roentgenol 2008;190(01):191-199
- Lodeizen O, de Bruin M, Eggener S, et al. Ablation energies for focal treatment of prostate cancer. World J Urol 2019;37(03):409-418
- Park J, Lee JS, Cho JH, Kim S. Effects of high-intensity-focused ultrasound treatment on benign uterine tumor. J Korean Med Sci 2016;31(08):1279-1283
- Liu XF, Huang LH, Zhang C, Huang GH, Yan LM, He J. A comparison of the cost-utility of ultrasound-guided high-intensity focused ultrasound and hysterectomy for adenomyosis: a retrospective study. BJOG 2017;124(Suppl 3):40-45